Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Trial Updates

View all
1:52
ZUMA-1 safety management study: early use of steroids helps manage side effects
Marie José Kersten • 30 Jan 2020
1:55
CRISPR/Cas9 edited T-cells in MM and sarcoma
Bruce Levine • 30 Jan 2020

Manufacturing

View all
3:59
UCL CAR T-cell program: advancing CAR T-cell manufacturing
Claire Roddie • 30 Jan 2020
2:09
Accessible and affordable CAR T-cell production in academia: the Barcelona group’s experience
Manel Juan Otero • 30 Jan 2020

Nursing

View all
4:24
CAR-T Meeting 2020: nurses’ sessions highlights
John Murray • 30 Jan 2020
2:49
The role of nurses in CAR T-cell therapy
Erik Aerts • 30 Jan 2020

Patient Advocacy

View all
2:20
CAR T-cell therapy access and reimbursement: the patient’s perspective
Bregje Verhoeven • 30 Jan 2020
3:04
Patient perspectives of CAR T-cell regulation
Natacha Bolaños • 30 Jan 2020

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals